BENKOWITZ MICHAEL bought UTHR

September 9, 2025 · Form 4 insider transaction

BENKOWITZ MICHAEL bought 11,375 shares of United Therapeutics Corporation at $397.41 per share, a transaction worth $4.52M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
11,375
Price
$397.41
Total value
$4.52M
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 9, 2025
Filing dateSeptember 10, 2025
Shares owned after11,375
OwnershipIndirect
10b5-1 planYes
AmendedNo

Footnotes

This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025.; Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.

View the original Form 4 on SEC EDGAR